Entrada Therapeutics, Inc. (TRDA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 425.3M |
| Enterprise Value | 385.84M |
| P/E Ratio | -1.36 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 51.68 |
| Price/Book Ratio | 1.12 |
| Enterprise/Revenue | 35.36 |
| Enterprise/EBITDA | -0.87 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -40.58 |
| Operating Margin | -43.04 |
| Return On Assets | -0.6 |
| Return On Equity | -0.64 |
| Revenue | 25.42M |
| Revenue/Share | 0.09 |
| Gross Profit | 21.33M |
| EBITDA | -138.73M |
| Net Income | -143.75M |
| Diluted EPS | -3.47 |
| Total Cash | 193.02M |
| Total Cash/Share | 4.56 |
| Total Debt | 47.31M |
| Total Debt/Equity | 0.24 |
| Current Ratio | 7.85 |
| Book Value Per Share | 4.68 |
| 52-Week Change | -31.82 |
| 52-Week High | 16.45 |
| 52-Week Low | 4.11 |
| Moving Average 50 Days | 5.75 |
| Moving Average 200 Days | 8.58 |
| Average Volume | 346,006 |
| Shares Outstanding | 39.15M |
| % Held by Institutions | 69.35 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |